Botanix Pharmaceuticals
+61 8 6285 0083
At a Glance
- Headquarters
- Unknown, US
About
Botanix Pharmaceuticals is an ASX-listed dermatology company focused on developing and commercializing novel treatments for skin diseases and infections. Its lead product, Sofdra (sofpironium topical gel), received FDA approval in June 2024 for primary axillary hyperhidrosis and was launched in the US in February 2025.
Capabilities & Markets
Directory supply chains
Products
Materials worked
End markets served
Classification
NAICS Codes
Compliance & Registrations
Certifications
FDA Approval
compliance_program
Filterable Certifications & Statuses
FDAAPPROVAL
Related Manufacturers
DermAvance Pharmaceuticals, IncDermAvance Pharmaceuticals is a privately held dermatology pharmaceutical company focused on acquiring, developing, and commercializing innovative products for the aesthetic dermatology market. The company markets prescription and cosmeceutical products to plastic surgeons, dermatologists, and aesthetic physicians for facial skin rejuvenation.MALVERN, PA
Summers LaboratoriesSummers Laboratories manufactures dermatological skin care products for various skin conditions. The company produces treatments for acne, dry skin, psoriasis, eczema, brittle nails, and vitiligo, and donates products to Camp Horizon, a camp for children with severe skin conditions.COLLEGEVILLE, PA
Formula 2 Skin CareFormula 2 Skin Care develops pharmacist-formulated products to address severely dry, cracked, irritated, or itchy skin conditions. The company manufactures its products in a facility near Daytona Beach, Florida.AVONDALE, PA
ARxARx is a full-service partner for pharmaceutical and biopharma companies specializing in developing novel drug delivery systems through Oral Thin Films and Transdermal Patches. The company manufactures dissolvable films and patches to improve control, bioavailability, and patient experience.GLEN ROCK, PA